Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

When to Initiation Antitumor Therapy for Tumor Patients With COVID19 Infection

NCT06006845 is registered in ClinicalTrials.gov with The Seventh Affiliated Hospital of Sun Yat-sen University as lead sponsor.

NCT NCT06006845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06006845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
When to Initiation Antitumor Therapy for Tumor Patients With COVID19 Infection
Lead sponsor
The Seventh Affiliated Hospital of Sun Yat-sen University
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2022
Completion date
August 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, tumor